Texas Administrative Code
Title 22 - EXAMINING BOARDS
Part 9 - TEXAS MEDICAL BOARD
Chapter 170 - STANDARDS FOR USE OF INVESTIGATIONAL AGENTS
Subchapter A - STANDARDS FOR USE OF INVESTIGATIONAL DRUGS, BIOLOGICAL PRODUCTS, OR DEVICES
Section 170.1 - General Standards for Use of Investigational Agents

Universal Citation: 22 TX Admin Code § 170.1

Current through Reg. 50, No. 13; March 28, 2025

(a) Pursuant to Chapter 489 of the Texas Health and Safety Code, a physician who administers or provides for the use of investigational drugs, biological products, or devices must:

(1) comply with all applicable state and federal laws and rules;

(2) meet the standard of care;

(3) comply with ethical standards including Declaration of Helsinki and the Belmont Report;

(4) maintain adequate medical records; and

(5) document the proposed investigational agent to be used:

(A) is included in an FDA/NIH approved protocol or study; or

(B) is approved by an Institutional Review Board (IRB) meeting standards under subsection (b) of this section.

(b) The approving IRB must be:

(1) affiliated with an academic setting or a Texas-licensed hospital;

(2) accredited by the Association for the Accreditation of Human Research Protection Programs, Inc.

(3) registered by the U.S. Department of Health and Human Services Office for Human Research Protection, pursuant to 21 CFR Part 56; or

(4) accredited by a national accrediting organization recognized by the board.

Disclaimer: These regulations may not be the most recent version. Texas may have more current or accurate information. We make no warranties or guarantees about the accuracy, completeness, or adequacy of the information contained on this site or the information linked to on the state site. Please check official sources.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.